解锁精度:双特异性T细胞参与者和泌尿瘤学的下一个前沿
Joecelyn Kirani Tan1, Sri Vidya Niharika Gullapalli2, Pratima Chapagain3
1Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Critical reviews in oncology/hematology
|November 22, 2025
概括
双特异性T细胞参与剂 (BiTEs) 通过激活T细胞对抗瘤来治疗泌尿系统癌症具有前途. 需要进一步的研究来克服毒性和瘤微环境等挑战,以获得更广泛的临床成功.
科学领域:
- 尿瘤学 尿瘤学
- 免疫治疗是一种免疫疗法.
- 癌症治疗方法 癌症治疗方法
背景情况:
- 泌尿系统癌症 (前列腺癌,膀癌,脏癌,丸癌) 由于发病率,死亡率和治疗耐药性而带来了重大挑战.
- 双特异性T细胞参与剂 (BiTEs) 是一种新的免疫治疗方法,向瘤抗原,以增强T细胞介导的抗瘤免疫力.
研究的目的:
- 审查BTE在尿道癌症中的应用.
- 要突出临床结果,挑战,和未来的前景的BTE在尿瘤学.
主要方法:
- 在泌尿癌治疗中对双特异性T细胞参与剂 (BiTEs) 的文献综述.
- 对BTE的临床结果,疗效和安全数据的分析.
主要成果:
- 在克服尿道癌的传统疗法和免疫检查点抑制剂的局限性方面,BITE显示出潜力.
- 例如包括治疗前列腺癌的帕索图克苏马布和治疗膀癌的CD3×B7-H3 BiTE.
- 优点包括选择性T细胞激活和低剂量的潜在疗效.
结论:
- 双TEs提供了显著的优势,但面临着挑战,包括向瘤毒性和免疫抑制瘤微环境 (TME).
- 组合疗法 (例如,免疫检查点抑制剂,瘤病毒) 和技术进步对于提高疗效至关重要.
- 优化策略和扩大临床试验对于巩固BiTEs在泌尿瘤学免疫治疗中的作用至关重要.
更多相关视频
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.6K
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
10.1K
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K